Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy.

Vaccines (Basel) · 2022 · PMC9144765 · PMID 35632534

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Figure 2 shows a decreasing trend of antibody levels of rSBA MenC titres ≥ 1:8 from 67.7% (95% CI: 48.6–83.3%) at one year after vaccination to 36.7% (95% CI: 19.9–56.1%) at five years after vaccination (chi-square for linear trend, p < 0.001).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.